Changes in Serum Proteomic Patterns by Presurgical α-Tocopherol and l-Selenomethionine Supplementation in Prostate Cancer

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-04-0679PMID 16030104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monitoring the serological proteome: the latest modality in prostate cancer detection.

  2004cited by this paper
• Use of proteomic patterns to screen for gastrointestinal malignancies.

  2004cited by this paper
• DNA stability and serum selenium levels in a high-risk group for prostate cancer.

  2004cited by this paper
• Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry.

  2004cited by this paper
• Commentary on: Mobley AJ, Lam YW, Lau KM, Pais VM, Lesperance JO, Steadman B, et al. Monitoring the serological Proteome Colon, the latest modality in prostate cancer detection. J Urol 2004; 172: 331-7.

  2004cited by this paper
• Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis.

  2003cited by this paper
• Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial

  2003cited by this paper
• Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.

  2003cited by this paper
• Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

  2002cited by this paper
• Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

  2002cited by this paper
• Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.

  2002cited by this paper
• Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients.

  2002cited by this paper
• Use of proteomic patterns in serum to identify ovarian cancer.

  2002cited by this paper
• Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.

  2002cited by this paper
• Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development: Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia

  2002cited by this paper
• Prostate cancer early detection: a clinical perspective.

  2001cited by this paper
• Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

  1999influential reference
• The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer.

  1998cited by this paper
• Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin.

  1998cited by this paper
• The α-tocopherol, β-carotene cancer prevention study

  1997cited by this paper
• Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

  1996cited by this paper
• Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial

  1996cited by this paper
• The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.

  1994cited by this paper

• Antioxidant Food Supplementation in Cancer: Lessons from Clinical Trials and Insights from Preclinical Studies

  2025cites this paper
• Natural Health Products for Anti-Cancer Treatment: Evidence and Controversy

  2024cites this paper
• Systemic vitamin intake impacting tissue proteomes

  2020cites this paper
• Genetic and genomic technologies and diagnosis of aggressive prostate cancer

  2017cites this paper
• “Omics” of Selenium Biology: A Prospective Study of Plasma Proteome Network Before and After Selenized-Yeast Supplementation in Healthy Men

  2016cites this paper
• Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for Protein markers with potential clinical utility

  2013cites this paper
• How Does Foodomics Impact Optimal Nutrition

  2013cites this paper
• Complementary and alternative therapies

  2011cites this paper
• Molecular targets of selenium in prostate cancer prevention (Review).

  2011cites this paper
• Nutrigenomics in human intervention studies: current status, lessons learned and future perspectives.

  2011cites this paper
• A new decade of rational examination replaced what was in hindsight two decades of irrational exuberance.

  2010cites this paper
• nium-Responsive Proteins in the Sera of Selenium-iched Yeast – Supplemented Healthy African B & P erican and Caucasian

  2010cites this paper
• Chemoprevention of prostate cancer: breakthroughs and controversies

  2010cites this paper
• Selenium-Responsive Proteins in the Sera of Selenium-Enriched Yeast–Supplemented Healthy African American and Caucasian Men

  2010cites this paper
• γ‐Tocopherol‐enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice

  2009cites this paper
• PROSTATE CANCER CHEMOPREVENTION BY DIETARY PHYTOCHEMICALS

  2009cites this paper
• Selenomethionine Induced Changes on the Binding of Spermine with DNA: A Study by Fourier Transform Raman and Fourier Transform Infra Red Spectroscopy

  2009cites this paper
• Potential stages for prostate cancer prevention with selenium: implications for cancer survivors.

  2009cites this paper
• Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.

  2009cites this paper
• Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials.

  2008cites this paper
• Strategy for the application of therapy in prostate cancer.

  2008cites this paper
• Selenium in food and the human body: a review.

  2008cites this paper
• Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer

  2008cites this paper
• DNA Damage, a Biomarker of Carcinogenesis: Its Measurement and Modulation by Diet and Environment

  2007cites this paper
• The use of proteomic techniques to explore the holistic effects of nutrients in vivo

  2006cites this paper
• Current and future status of prostate cancer chemoprevention

  2006cites this paper
• Proteomic analysis in cancer research: potential application in clinical use

  2006cites this paper
• Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

  2006cites this paper
• Incorporating ‘omics’ approaches to elucidate the role of selenium and selenoproteins in cancer prevention

  2006cites this paper